The Life Sciences Industry Conference 2026 has confirmed a speaker lineup that reflects the full complexity of what AI-ready manufacturing requires, from data infrastructure and digital systems to regulatory trust, workforce capability, and strategic leadership. Taking place on Thursday, 22 October 2026, at the Crowne Plaza Hotel, Santry, the conference brings together practitioners with direct experience of scaling AI and digital transformation across regulated life sciences manufacturing environments.

William Fahey, Data Science Lead at Pfizer, opens the conference as keynote speaker. His work centres on scaling artificial intelligence, machine learning, and generative AI across Pfizer's global biopharmaceutical manufacturing network, grounding the day's discussions in what enterprise-wide AI deployment actually demands at the level of data science leadership within one of the world's largest pharmaceutical manufacturers.

The plant floor practitioner sessions bring together three speakers with deep operational credentials. James Murphy, COO at Eirgen Pharma, contributes over twenty years of manufacturing and supply chain management experience. Colm Bambury, Director of Digital Technology at Amgen, works across manufacturing systems, automation, MES, data, and analytics, applying AI to create measurable value for teams operating in GMP-regulated environments. Trevor Marshall, Head of Consulting for Life Science Manufacturing at Cognizant, adds twenty-five years of experience partnering with life sciences customers to design and deliver manufacturing and digital technologies at scale.

Governance and regulatory credibility are addressed through Alice Redmond, Chief Risk and Quality Officer at CAI, who specialises in FDA-guided risk validation, and Ger McCabe, Managing Director and Co-Owner at Biostor Ireland, whose organisation brings the regulatory trust frameworks that life sciences manufacturers depend on when implementing new technology without compromising compliance.

The strategy and research dimension of the programme draws on Matt Moran, CEO of Matt Moran Consulting and founder of BioPharmaChem Ireland at Ibec, who contributes three decades of pharmaceutical sector leadership. Araz Raoof, PhD, MBA, Executive Director at ARC Hub for Therapeutics, brings a development pipeline perspective shaped by over eighty projects progressed to development. Professor Damien Thompson of the University of Limerick and Director at Rinn Pharma leads research in advanced nano-materials with direct applications across health and sustainability manufacturing.

Dinny Crowe, VP of Operations for Ireland at ABM, rounds out the lineup with over thirty years in facilities management across pharmaceutical, data centre, and healthcare clients — a reminder that AI-ready manufacturing depends as much on operational infrastructure as on digital systems.

Together, the lineup reflects the conference's commitment to a programme where every session is shaped by people who run manufacturing sites, not just those who advise them.

Visit the Life Sciences Industry Conference 2026 website to book your place and receive programme updates ahead of the October event.